Differentiating Right-sided Epiploic Appendagitis From Diverticulitis
ConditionEpiploic Appendagitis
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age20+
SponsorNational Taiwan University Hospital
About this trial
This study will perform a retrospective analysis of adult patients who presented to the emergency department of National Taiwan University Hospital, Hsin-Chu and Yun-Lin Branches between January 2022 and December 2025 and were diagnosed with either right-sided epiploic appendagitis or right-sided colonic diverticulitis based on CT findings. Clinical presentations, laboratory data, ultrasound and CT imaging characteristics, treatment strategies, and clinical outcomes will be compared between the two groups. The study aims to identify imaging and clinical features that may facilitate the rapid differentiation of these two conditions in the emergency department.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
patients more than 20 years, with CT-confirmed right-sided epiploic appendagitis
Disqualifiers
patients less than 20 years with other abdominal pathologies
Trial population
patients more than 20 years with CT-confirmed right-sided epiploic appendagitis
Trial design
Design model
Case-control
Time perspective
Retrospective
Treatments tested in this trial
Not listed
Trial groups
50 Participants
are grouped into 2 trial groupsGroup A: EA case
Group B: diverticulitis control
Trial outcomes
Primary outcomes
1
clinical parameters
physiological parameters
Time frame
one yearLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: